CTXR

Citius Pharmaceuticals Inc. (CTXR), headquartered in Cranford, New Jersey, is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for critical care environments. The firm is focused on addressing substantial unmet medical needs with a promising pipeline of products aimed at improving patient outcomes in hospital settings. Citius leverages cutting-edge technologies and forms strategic collaborations to position itself as a leader in the critical care sector, contributing to transformative advancements in patient care. With a strong commitment to innovation and a clear strategic vision, Citius presents a compelling investment opportunity in the biopharmaceutical arena for institutional investors.